Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 843

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 843
---
 and 2024 Warrants (within additional paid in capital) on a relative fair value basis. Subsequent fair value measurement is not required as long as the instrument continues to be classified in equity. The Company determined that the fair value of the 2024 Warrants in connection with Notes issued amounted to $ 6,520,056and recognized as a debt discount with an offset to additional paid in capital.

Convertible notes and debt discount

Convertible notes issued (including accrued interest) outstanding, and converted are as follows:

| Balance as of January 1, 2023         |     | Convertible notespayable |           — |   |
|:--------------------------------------|:----|:-------------------------|------------:|:--|
| Issuance of convertible notes payable |     |                          |   2,685,000 |   |
| Interest expense                      |     |                          |      13,564 |   |
| Balance as of December 31, 2023       |     | $                        |   2,698,564 |   |
| Issuance of convertible notes payable |     |                          |  28,568,000 |   |
| Interest expense                      |     |                          |   2,859,878 |   |
| Converted to common stock             |     |                          | (34,126,442 | ) |
| Balance as of December 31, 2024       |     | $                        |           — |   |

Debt discount related to the convertible notes are as follows:

| Balance as of January 1, 2023                                                         |     | Debt discount |          — |   |
|:--------------------------------------------------------------------------------------|:----|:--------------|-----------:|:--|
| Debt issue costs                                                                      |     |               |   (242,530 | ) |
| Debt discount associated with make-whole features recognized                          |     |               |   (137,000 | ) |
| Amortized to interest expense                                                         |     |               |      5,124 |   |
| Balance as of December 31, 2023                                                       |     | $             |   (374,406 | ) |
| Debt issue costs                                                                      |     |               | (1,218,525 | ) |
| Debt discount associated with make-whole features recognized                          |     |               | (2,402,228 | ) |
| Debt discount associated with warrants recognized                                     |     |               | (6,520,058 | ) |
| Amort